Poet Technologies Sank Today: Is the Stock a Buy Now?
Poet Technologies sank today, sparking questions about its future. This analysis breaks down what happened, what it m...
Understanding when to focus on short-term versus long-term investments can greatly impact your financial strategy. This guide helps you make informed decisions.
27,724 articlesPoet Technologies sank today, sparking questions about its future. This analysis breaks down what happened, what it m...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
OpenAI just signaled might delay its IPO, sending ripples through AI investors and chipmakers. This guide breaks down...
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A leading cybersecurity stock surged about 62% in 2026, propelled by artificial intelligence (ai) innovations. This a...
February’s jobs data showed a modest payroll gain, but economists say AI is not the main driver of the softness. The ...
Anthropic’s IPO path is shaping AI headlines, but patient investors can still win by focusing on established tech gia...
On June 12, the stock market today, june delivered a space-focused pivot as AST SpaceMobile fell after gains and Spac...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover what Universal (UVV) 2026 earnings mean for investors. This plain-English guide breaks down performance driv...
Netflix has chased big bets beyond subscribers, but the road from ambition to profits is rocky. This article breaks d...
A legendary investor steps back, and a provocative figure—warren buffett's final $373—sparks fresh questions about ma...